Morten Juhl

Medicine & Life Sciences

1. Stromal Cells 100%
2. Mesenchymal Stem Cells 62%
3. Positron-Emission Tomography 37%
4. Adipose Tissue 30%
5. 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane 29%
6. Swine 22%
7. Synucleins 21%
8. Heart Failure 20%
9. Stroke Volume 20%
10. Blood Platelets 18%
11. Alginates 18%
12. 64Cu-DOTATATE 17%
13. Hydrogels 17%
14. Injections 16%
15. Cardiomyopathies 15%
16. Cell- and Tissue-Based Therapy 14%
17. Monocytes 14%
18. Myocardial Infarction 13%
19. Cattle 12%
20. Lewis X Antigen 12%
21. Bioreactors 11%
22. Fibroblasts 11%
23. Cryopreservation 11%
24. Miniature Swine 11%
25. Macrophages 10%
26. Serum 10%
27. Crowding 10%
28. Coculture Techniques 10%
29. Lymphocytes 10%
30. Cellular Reprogramming 10%
31. Protein Aggregates 9%
32. Blood Cells 9%
33. Fluorodeoxyglucose F18 9%
34. THP-1 Cells 9%
35. N-methyl-2-(4'-methylaminophenyl)-6-hydroxybenzothiazole 9%
36. Genes 9%
37. Parkinson Disease 9%
38. Therapeutics 9%
39. Alzheimer Disease 9%
40. Oxidopamine 9%
41. Phytohemagglutinins 8%
42. Mitogens 8%
43. Proteome 8%
44. Dendritic Cells 7%
45. Placebos 7%
46. Brain 7%
47. In Vitro Techniques 7%
48. Myocardial Ischemia 7%
49. Cardiology 7%
50. Extracellular Matrix 7%